03.05.2023 19:00:11
|
Medacta showcases NextAR Spine MIS LT procedure at Spine Week, efficiently complementing operative workflow for spine surgery
Medacta Group SA
/ Key word(s): Product Launch
MEDIA RELEASE CASTEL SAN PIETRO, May 3, 2023 - Medacta Group SA (Medacta, SIX:MOVE), a Swiss company specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for Joint Replacement, sports medicine, and spine surgeries, showcases its innovative NextAR Spine MIS LT procedure at Spine Week. This procedure combines the augmented reality surgical application NextAR Spine and the M.U.S.T. LT percutaneous spinal fixation platform, creating a perfect synergy between optimized workflow, versatility, and personalized implant choice, and well-established execution in minimally invasive surgeries. By combining NextAR Spine with M.U.S.T. LT, you get an immediate and simple solution for an accurate percutaneous fixation. From the design phase, we aimed to make the procedure more efficient and reproducible and perfectly integrated into the operative workflow," says Prof. Dr. Bernhard Meyer, Director of the Neurosurgical Clinic of the Technical University of Munich, Germany. Dr. Andrew Kam, Westmead Hospital, adds, With NextAR MIS LT, I was impressed with how the NextAR technology has been enhanced in percutaneous surgeries. The immediate access to pertinent data and the versatility of the M.U.S.T. LT system improve the procedure's workflow and the patient's outcomes. The NextAR Spine MIS LT procedure combines:
In line with Medacta's philosophy of healthcare sustainability, the NextAR platform is offered as a hardware system with limited capital investment and the ability to host software for multiple applications. The platform represents an optimal solution worldwide, particularly for US Ambulatory Surgery Centers (ASCs). The NextAR Augmented Reality Surgical Platform is part of Medacta's MySolutions Personalized Ecosystem, an advanced network of digital solutions designed to improve patient outcomes and healthcare efficiency. MySolutions embodies Medacta's holistic approach to personalized medicine, aiming to bring value to every step of the patients journey from preoperative through postoperative care. NextAR is also supported by the comprehensive, tailored educational offerings provided by the M.O.R.E. Institute. With an international network of expert surgeons, the M.O.R.E. Institute is at the forefront of education on spine procedures and products with personalized, high-level educational pathways. With Medacta, the surgeon is never alone. To learn more about the NextAR Spine MIS LT procedure, visit Medacta during Spine Week at booth number B13. Contact
ABOUT MEDACTA
RELATED TRADEMARKS Additional features: File: Medacta showcases NextAR Spine LT procedure at Spine Week, efficiently complementing operative workflow for spine surgery
End of Media Release |
Language: | English |
Company: | Medacta Group SA |
Strada Regina | |
6874 Castel San Pietro | |
Switzerland | |
Phone: | +41 91 696 6060 |
E-mail: | info@medacta.ch |
Internet: | www.medacta.com |
ISIN: | CH0468525222 |
Listed: | SIX Swiss Exchange |
EQS News ID: | 1622757 |
End of News | EQS News Service |
|
1622757 03.05.2023 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Medactamehr Nachrichten
21.02.25 |
SPI-Titel Medacta-Aktie: So viel Gewinn hätte ein Investment in Medacta von vor 5 Jahren abgeworfen (finanzen.at) | |
14.02.25 |
SPI-Titel Medacta-Aktie: So viel hätten Anleger mit einem Investment in Medacta von vor 3 Jahren verdient (finanzen.at) | |
07.02.25 |
SPI-Papier Medacta-Aktie: So viel hätte eine Investition in Medacta von vor einem Jahr abgeworfen (finanzen.at) | |
04.02.25 |
Schwacher Handel in Zürich: SPI liegt zum Ende des Dienstagshandels im Minus (finanzen.at) | |
04.02.25 |
Schwacher Wochentag in Zürich: SPI verbucht nachmittags Verluste (finanzen.at) | |
04.02.25 |
Börse Zürich: SPI zeigt sich leichter (finanzen.at) | |
04.02.25 |
Medacta Group SA reports significant above-market revenue growth of 16.2% in constant currency in 2024 (EQS Group) | |
29.01.25 |
Börse Zürich in Grün: SPI zum Ende des Mittwochshandels in der Gewinnzone (finanzen.at) |
Analysen zu Medactamehr Analysen
Aktien in diesem Artikel
Medacta | 78,60 | 2,12% |
|